Search results
Results from the WOW.Com Content Network
YCT529 is a drug which acts as a potent and selective antagonist of the vitamin A receptor retinoic acid receptor alpha (RAR-α). In studies on mice it produced a 99% reduction in sperm production, and it has proceeded to early stage human clinical trials as a potential male contraceptive.
YourChoice Therapeutics, Inc., for example, started phase one human clinical trials of YCT-529, with the goal of becoming the first hormone-free, reversible male birth control pill. In initial ...
The gel was male birth control. ... YourChoice Therapeutics said a very small trial in the U.K. — just 16 men — showed that its nonhormonal pill, YCT-529, was safe and free of side effects ...
No male birth control product has made it to market, but over the past year, there has been promising early progress on new treatments — including a pill, a gel that’s rubbed onto the skin and ...
Male contraceptives, also known as male birth control, are methods of preventing pregnancy by interrupting the function of sperm. [1] The main forms of male contraception available today are condoms , vasectomy , and withdrawal , which together represented 20% of global contraceptive use in 2019.
An experimental contraceptive drug was effective at temporarily disabling sperm in male ... The medication does not lead to the unwanted side effects of conventional hormonal birth control pills.
The break week is comparable to the placebo week for combined oral birth control pills ("the Pill"), and the birth control effect is maintained during this period. Extended use regimens (seven-week, quarterly, or annual) involving back-to-back use of (2, 4, or 17) rings have been studied in clinical trials, but are not currently approved. [7 ...
For premium support please call: 800-290-4726 more ways to reach us